Correlation Between Orthopediatrics Corp and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orthopediatrics Corp and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orthopediatrics Corp and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orthopediatrics Corp and Neuropace, you can compare the effects of market volatilities on Orthopediatrics Corp and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orthopediatrics Corp with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orthopediatrics Corp and Neuropace.

Diversification Opportunities for Orthopediatrics Corp and Neuropace

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Orthopediatrics and Neuropace is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Orthopediatrics Corp and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Orthopediatrics Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orthopediatrics Corp are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Orthopediatrics Corp i.e., Orthopediatrics Corp and Neuropace go up and down completely randomly.

Pair Corralation between Orthopediatrics Corp and Neuropace

Given the investment horizon of 90 days Orthopediatrics Corp is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Orthopediatrics Corp is 1.84 times less risky than Neuropace. The stock trades about -0.03 of its potential returns per unit of risk. The Neuropace is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  402.00  in Neuropace on August 27, 2024 and sell it today you would earn a total of  664.00  from holding Neuropace or generate 165.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Orthopediatrics Corp  vs.  Neuropace

 Performance 
       Timeline  
Orthopediatrics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orthopediatrics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Neuropace 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Orthopediatrics Corp and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orthopediatrics Corp and Neuropace

The main advantage of trading using opposite Orthopediatrics Corp and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orthopediatrics Corp position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Orthopediatrics Corp and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Correlations
Find global opportunities by holding instruments from different markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories